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Abstract
Background: Until recently, viral infections in patients with hematological malignancies were concerns primarily in
allogeneic hematopoietic stem cell transplant (HSCT) recipients. During the last years, changed treatment regimens for non-
transplanted patients with hematological malignancies have had potential to increase the incidence of viral infections in this
group. In this study, we have prospectively investigated the prevalence of a broad range of respiratory viruses in
nasopharyngeal aspirate (NPA) as well as viruses that commonly reactivate after allogeneic HSCT.
Methodology/Principal Findings: Patients with hematological malignancies and therapy induced neutropenia (n=159)
were screened regarding a broad range of common respiratory viruses in the nasopharynx and for viruses commonly
detected in severely immunosuppressed patients in peripheral blood. Quantitative PCR was used for detection of viruses. A
viral pathogen was detected in 35% of the patients. The detection rate was rather similar in blood (22%) and NPA (18%) with
polyoma BK virus and rhinovirus as dominating pathogens in blood and NPA, respectively. Patients with chronic
lymphocytic leukemia (CLL) (p,0.01) and patients with fever (p,0.001) were overrepresented in the virus-positive group.
Furthermore, viral findings in NPA were associated with upper respiratory symptoms (URTS) (p,0.0001).
Conclusions/Significance: Both respiratory viral infections and low titers of viruses in blood from patients with neutropenia
were common. Patients with CLL and patients with fever were independently associated to these infections, and viral
findings in NPA were associated to URTS indicating active infection. These findings motivate further studies on viruses’
impact on this patient category and their potential role as causative agents of fever during neutropenia.
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Introduction
Reactivation of viruses in blood as well as viral respiratory tract
infections has a significant impact on the morbidity and mortality of
allogeneic hematopoietic stem cell transplant (HSCT) recipients [1–
4]. Although a rather high prevalence of respiratory viruses in
neutropenic patients with fever is reported [4,5], the impact of viral
infections in the non-transplant setting of neutropenic hematolog-
ical patients is less studied. In addition, reactivation of cytomega-
lovirus (CMV) is reported in hematological neutropenic patients
that have not undergone allogeneic HSCT [6–8]. Fever is often the
only sign of infectionin the immunocompromised patient, and since
establishing the cause of fever in neutropenic patients is difficult,
empiric administration of broad spectrum antibiotics is in common
usage [9,10]. This strategy has substantially decreased the mortality
rate in this patient group, but bacterial infection is documented in
only approximately one-third or fewer of the febrile episodes [11–
14]. Most patients with hematological malignancies remain at home
between courses of chemotherapy, including neutropenic phases,
and are thus exposed to all common pathogens circulating in the
society. Consequently, the epidemiology of these infections in
hospitalized patients mirrors that in outpatients [15].
Here, in a setting of neutropenic hematological patients, other
than allogeneic HSCT recipients, we prospectively evaluated the
presence of a broad range of respiratory viruses in nasopharyngeal
aspirate (NPA) as well as viruses that commonly reactivate after
allogeneic HSCT.
Materials and Methods
Ethics Statement
Patients were, after giving their informed written consent,
eligible for enrollment. The study was approved by The Regional
Ethical Review Board in Stockholm (www.epn.se).
Study population
During a 26-month period (Jan 2008–Feb 2010) adult patients
with hematological disorders who presented at the Karolinska
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participate in this study. Patients having undergone allogeneic
hematopoietic stem cell transplantation (HSCT) within the
previous two years and patients admitted to the Intensive Care
Unit were excluded from the study.
Sampling procedure
Patients with neutropenic fever were sampled for routine
microbial cultures upon admission or at the onset of fever during
a hospitalization. The additional study samples for detection of
viruses in blood and nasopharyngeal aspirates (NPA) were
collected within 72 hours of fever onset. Upon routine medical
appointments, unselected afebrile neutropenic patients were
prospectively sampled for the study samples only. Within 6 hours
from sampling, each NPA was stored at 280uC before analysis by
quantitative real-time PCR (qPCR). Serum was used for all blood
assays except those for cytomegalovirus (CMV) and adenovirus
(AdV), where whole blood and plasma were used, respectively.
Extraction and qPCR methods
Blood specimens for detection of Epstein-Barr virus (EBV),
CMV,andAdVwereextracted and analyzedbyqPCRasdescribed
[16]. For the other qPCRs, total viral nucleic acids were extracted
with QIAamp MinElute Virus Spin Kit (QIAGEN, US) according
to the manufacturer’s protocolwith 200 mL of specimens eluted into
50 mL of extract. The analysis of BK virus (BKV) is described
elsewhere [Multiplex real-time PCR assay for simultaneous
detection of cytomegalovirus, Epstein-Barr virus, adenovirus, and
BK polyomavirus, O ¨ hrmalm et al. In manuscript]. The qPCR for
parvovirus B19 (B19) was performed on an ABI 7500 Real-Time
PCR System (Applied Biosystems) and carried out in a total 50-mL
reaction mixture including 25 mL of TaqMan Universal PCR
Master Mix (Applied Biosystems) and 5 mL of template (Table 1).
The NPAs were analyzed on the same ABI System described above.
However, for RNA viruses, a MultiScribe and RNase Inhibitor Mix
(Applied Biosystems) was used. Newly developed primers and
probes are described in Table 1, whereas for human rhinovirus
(HRV) [17], human enterovirus (HEV) [18], influenza A virus (IFA)
[19], influenza B virus (IFB) [20], respiratory syncytial virus (RSV)
[21], and parainfluenza virus type 1 (PIV1) [22], the design is
described elsewhere. Quantification of viruses in blood was
achieved by comparing with plasmids of known concentrations.
Virus detection in nasopharynx was however judged qualitatively as
NPA was used as starting material. For CMV, EBV, and AdV the
dynamic range was 500 to 2610
8 copies/mL. Values of detectable
viral copies below this range were given as ‘‘,500’’. For BKV and
B19, the lower part of the dynamic range was 5 copies/reaction.
Values of detectable viral copies below 250 copies/mL blood were
considered as ‘‘,250.
Flow cytometry
In 99 patients where peripheral blood mononuclear cells were
isolated phenotype characterization was made by staining with two
sets of antibodies, BD Multitest (BD Biosciences, Sweden), against
the following cell surface markers; Set 1: CD3-FITC, CD8-PE,
CD45-PerCP, CD4-APC; Set 2: CD3-FITC, CD16/CD56-PE,
CD45-PerCP, CD19-APC according to the manufacturer’s
instructions. TruCount tubes (BD Biosciences) were used for an
absolute cell count.
Definitions and diagnostic criteria
Neutropenia was defined as an absolute neutrophil count
#500/mm
3. Fever was defined as a single temperature reading
$38.5uCo r.38.0uC that persisted for 1 hour. Upper respiratory
tract symptoms (URTS) were defined as onset of rhinorrhea,
sneezing, nasal congestion, cough, or hoarseness. For a diagnosis
of coagulase-negative staphylococci bacteremia, at least two
positive blood cultures were required.
Data collection and statistical analysis
Clinical and routinely collected laboratory data were extracted
from all patients’ medical records. Univariate analyses were
performed using Fischer’s exact test for categorical data. Non-
categorical variables were compared with the Mann-Whitney U-
test. Forward conditional binary logistic regression analysis was
performed with presence of virus as the dependent variable and all
parameters described in Table 2 with a p-value ,0.10 as
covariates. All tests were two-sided with p-value of ,0.05
considered significant. Software products used were Prism 5.00
for Windows and PASW Statistics 18.
Results
Study population
A total of 159 neutropenic patients were included (Table 2); 123
patients with fever, and 36 unselected afebrile neutropenic
patients. In case of participation at multiple neutropenic episodes
only the first was considered in this study. Of the 123 febrile
patients, 15 declined NPA and another one declined collection of
extra blood samples. The afebrile patients were sampled
completely. Thus, a total of 123 patients were included after
presenting with febrile neutropenia and study samples for virus
analysis were collected upon admission (27 patients) or within
24 hours (48 patients), within 48 hours (31 patients), and within
72 hours (17 patients) from admission.
Viral findings
In a total of 56 patients (35%) at least one virus type was
detected (Table 3). The detection rate was rather similar in blood
(22%) and in NPA (18%). In blood, BKV dominated followed by
CMV. In NPA HRV dominated followed by AdV. More than one
virus type was simultaneously detected in nine (16%) of the 56
virus-positive patients and all except one were sampled upon fever.
The viral load in blood samples was below 1 000 copies/mL with
only the following exceptions; one CMV finding of 1800 copies/
mL; four BKV findings of 3500, 4800, 7000 and 38000 copies/
mL; and one B19 finding of 9500 copies/mL (Figure 1). All these
were among the fever episodes.
Symptoms and signs of respiratory tract infection
Fifteen (58%) out of the 26 patients with a respiratory virus
detected in NPA had URTS compared to 20 (17%) out of 118
patients without URTS (OR=6.7, p,0.0001; Table 4). The
predominating reported URTS was cough followed by rhinorrhea,
sneezing or nasal congestion.
Viral and bacterial findings in patients with febrile
neutropenia
As mentioned above, one or more viral pathogens were detected
in 42% of the patients with febrile neutropenia. In 15 (29%) of
these patients there was concurrently a documented bacterial
infection. Conversely, bacterial infection was documented in 41
(33%) of the cases with febrile neutropenia and in 15 (37%) of
these virus co-occurred (Figure 2). There were no statistical
significant differences between the groups regarding C-reactive
protein (CRP) levels at fever onset or number of days with fever.
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higher for patients with documented bacterial infection (median 9
days, range 4–24) compared to those with virus only (median 6,
range 2–17) or no pathogen found (median 6, range 3–15; p,0.01
and p,0.001, respectively).
Characteristics and clinical parameters of patients with
and without virus
Chronic lymphocytic leukemia (CLL) was overrepresented in
the virus-positive group (11% vs. 1%, p,0.01; Table 2) and, even
though border line significant, viruses were more likely to be
detected among non-Hodgkin lymphoma (NHL) patients (45% vs.
28%, p=0.05). In contrast, few recipients of autologous HSCT
were virus positive (3.6% vs. 26%, p,0.001). Regarding the latest
treatment for the underlying disease, both steroid treatment and
monoclonal antibody therapy were associated with virus findings,
and eight of eleven given the combined drugs were positive. The
absolute counts of cell populations examined were lower in the
virus-infected group (Table 2). However, the differences did not
reach statistical significance with the exception of the CD4
+ T cell
count. The patients on prophylactic treatment with aciclovir were
underrepresented in the virus-positive group (38% vs. 56%,
p,0.05). A total of 52 (42%) out of the 123 patients with febrile
Table 1. Description of newly developed primers and probes used in the qPCR assays.
Virus Primer/Probe Sequence (59-39) Conc. (nM) PCR program
hCoV FW YGATAAAGCTGTAGCTCGCAAACT 900 48uC for 30 minR95uCf o r
10 minR40 cycles of 15 sec at
95uC and 60 sec at 60uC
ACGCGACCGTGCTGTAGC
GATCATGAGATATCTGTTCAGAAGAAAATT
CAGGGAATCATCTGTTCAAAAGAA
REV GATTATCCAATTTACGAACCATGCTA 900
GCTTGATTATCTAACTTACGCACCATACTA
ACATATCCAAACGTCTTAACATTCCA
AAACGTCGGAGCATGCCA
PRO VIC-GATAAGAAGAGTAARGTTGTTTC-MGB 225
VIC-TGGCTGAACAAGCTG-MGB
hMPV FW AAAGCATTAGGCTCATCCTCTACAG 300
AAAGCTTTAGGCTCATCTTCAACAG
AAAGCATTAGGCTCATCATCTACAGG
REV ATTGTTAGATGACCTGGCAATGAC 300
GTTGGATGACCTGGCAATGAC
TGTTGGATGATCTGGCAATGAC
TGTTGTTAGATGATCTGGCAATGAC
TGTTAGATGACCTGGCGATGAC
PRO NED-AGCAAAGCAGAAAGT-MGB 225
IFB PRO
a 6FAM-CAGATCTGTGCAGTTGAG-MGB
PIV2 FW TTACCTAAGTGATGGAATCAATCGC 300
REV TCTTTYTCAGAYCTTGTAGCTACATAGCA 300
PRO NED-AAGCTGTTCAGTCACTGC-MGB 175
PIV3 FW TCCCCATGGACATTCATYGTT 900
REV TGGCAYAGCAARTTACAATTAGGAA 900
PRO NED-TGCCATGTCCATTTTA-MGB 175
PIV4 FW CCAGTCAAATCAAYTGCCTCYG 900
REV GATCTCTRATGCATAGTTCGCAAATT 900
PRO NED-CATGTGGAAGATGTCC-MGB 225
B19 FW CCAGGCGCCTGGAACA 50 50uC for 2 minR95uC for
10 minR40 cycles of 15 sec at
95uC and 60 sec at 60uC
REV TCGGAGGAAACTGGGCTTC 300
TTCGGAGGAAACTGAGCTTCC
PRO 6FAM-CGGGACCAGTTCAGGA-MGB 250
NOTE. Conc, concentration; FW, forward; REV, reverse; PRO, probe; hCoV, human coronavirus; hMPV, human metapneumovirus; IFB, influenza B virus; PIV, parainfluenza
virus; B19, parvovirus B19.
aProbe modified, otherwise as described by Tiveljung et al [20].
doi:10.1371/journal.pone.0036543.t001
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patients without fever (OR=5.9, p,0.001). This was true for
viruses detected in blood (OR=3.9, p,0.05) as well as viruses
detected in NPA (OR=11, p,0.01; Table 4). As reactivation of
viruses in blood is associated with immunosuppression, we
performed univariate analyses of the characteristics in table 2
regarding the febrile and non-febrile patients. There were no
differences regarding gender, age, or underlying disease. However,
117 (95%) of the febrile patients and only 30 (83%) of the afebrile
patients had antineoplastic drugs included in their latest treatment
(p,0.5), and there was also a difference in the use of steroids (30%
vs. 11%, p,0.05). The cell count for all populations except
monocytes were significantly higher in the afebrile patients
(p,0.001). After multivariate regression analysis with presence of
virus dependent variable and parameters in Table 2 with a p value
less than 0.10 as covariates, CLL and fever remained as
independently associated to presence of virus (OR=7.5, p,0.01
and OR=13, p,0.0001), respectively. There were no reports on
hemorrhagic cystitis in the cases of detectable BKV. Furthermore,
we were unable to show an association of elevated serum levels of
creatinine and presence of BKV (data not shown).
Discussion
Using highly sensitive methods to identify a broad range of
viruses, we have estimated the prevalence of respiratory viruses
and viremia in hematological patients with neutropenia other than
allogeneic HSCT recipients. Viral infections were commonly
Table 2. Characteristics and laboratory data on neutropenic patients with and without viral findings.
Any virus No virus
Characteristics (n=56) (n=103) OR (95%CI)
a
No. of females (%) 21 (38) 44 (43) 0.80 (0.41–1.6)
Age, [years], median (range) 62 (20–86) 60 (25–86) n.s.
Underlying disease (%)
Acute leukemia/MDS 19 (34) 51 (50) 0.52 (0.27–1.0)
{
Chronic myeloid leukemia 0 (0) 1 (1) 0.60 (0.02–15)
Chronic lymphocytic leukemia 6 (11) 1 (1) 12 (1.4–104)**
Non-Hodgkin lymphoma 25 (45) 29 (28) 2.1 (1.0–4.1)
{
Myeloma 4 (7) 16 (16) 0.4 (0.13–1.3)
Hodgkin’s disease 1 (2) 3 (3) 0.61 (0.06–6.0)
Others 1 (2) 2 (2) 0.92 (0.08–10.4)
No. of autologous HSCT (%) 2 (4) 27 (26) 0.10 (0.02–0.46)***
Latest immunosuppressive treatment (%)
Monoclonal antibodies
b 15 (27) 10 (10) 3.4 (1.4–8.2)**
Antineoplastic chemotherapy 49 (88) 98 (95) 0.36 (0.11–1.2)
Steroids 22 (39) 19 (18) 2.9 (1.4–5.9)**
Days from treatment to sampling 12 (1–1064) 13 (2–632) n.s.
Cell count
c [/mm
3], median (range)
Leukocytes 200 (,100–1870) 400 (,100–3000) n.s.
Neutrophils ,100 (,100–500) ,100 (,100–500) n.s.
Lymphocytes 127 (14–18552) 202 (2.3–1332) n.s.
CD4
+ T cells 38 (0.06–769) 93 (1.4–606) *
CD8
+ T cells 45 (1.1–1568) 51 (0.14–537) n.s.
B cells 0.2 (0.02–15061) 0.4 (0.02–439) n.s
NK cells 11 (1.0–96) 16 (0.32–196) n.s.
Monocytes 21 (0.03–495) 86 (0.03–1337) n.s.
Prophylactic aciclovir (%) 21 (38) 58 (56) 0.47 (0.24–0.91)*
Presence of fever 52 (93) 71 (69) 5.9 (2.0–18)***
Bacterial infection
d 15 (27) 26 (25) 1.1 (0.52–2.3)
NOTE. Characteristics are presented in number and percentage of each group. Medians are followed by range. OR, odds ratio; CI, confidence interval; MDS,
myelodysplastic syndrome; NPA, nasopharyngeal aspirate.
a{,p #0.10;
*, p,0.05;
**, p,0.01;
***, p,0.001; ns, not significant.
bConsisting of rituximab, alemtuzumab, ofatumumab, anti thymoglobulin, or gemtuzumab.
cExcept for the leukocyte and neutrophil count, data on cell count were only available from 34 of the episodes with virus and 72 of the episodes without virus.
dNo bacterial diagnostics were performed on patients without fever but are here assumed to be negative.
doi:10.1371/journal.pone.0036543.t002
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of immunological cell types investigated, decline in the CD4
+ T
cell count was associated with these infections. Viral infections
were associated with fever, and specifically respiratory viruses in
NPA were associated with URTS. Although the majority of viral
Figure 1. Titers of viruses detected in blood.
doi:10.1371/journal.pone.0036543.g001
Table 3. Presence of viruses in peripheral blood and nasopharynx in the 159 patients with neutropenia.
Specimen Virus No. of positive (%) Co-existing viruses (n)
a
Blood BK polyoma virus (BKV) 18 (11.4) B19 (1), EBV (1), IFB (1), HRV (2)
n=158 Cytomegalovirus (CMV) 8 (5.1) B19 (1), RSV (1), AdV in NPA+HRV (1)
Parvovirus B19 (B19) 6 (3.8) CMV (1), BK (1), EBV (1)
Epstein-Barr virus (EBV) 6 (3.8) BK (1), B19 (1)
Adenovirus (AdV) 1 (0.6) -
No. of patients with at least one virus detected in blood 35 (22.2)
b
NPA Rhinovirus (HRV) 11 (7.6) AdV in NPA+CMV (1), BK (2)
n=144 Adenovirus (AdV) 6 (4.2) HRV+CMV (1)
Respiratory syncytial virus (RSV) 5 (3.5) CMV (1)
Influenza A virus (IFA) 1 (0.7) -
Influenza B virus (IFB) 2 (1.4) BK (1)
Metapneumovirus (HMPV) 2 (1.4) -
No. of patients with at least one virus detected in NPA 26 (18.1)
c
No. of patients with at least one virus detected in any specimen 56 (35.2)
NOTE. NPA, nasopharyngeal aspirate.
aAll co-existing viruses are also listed in the column of viruses. Thus, they are presented, but not counted, twice.
bPercentage of total sampling occasions where blood was investigated.
cPercentage of total sampling occasions where NPA was investigated.
doi:10.1371/journal.pone.0036543.t003
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bacterial co-infections were common.
The proportion of different virus species in NPA differed from
an earlier large study by Chemaly et al on adult hematological
patients [23]. HRV was the commonest finding in our study which
could be explained by the use of PCR instead of culture.
Moreover, the study by Chemaly et al was retrospective and only
included patients with documented positive viral culture. Howev-
er, our findings in NPA were comparable to recent studies on
children with febrile neutropenia [5,24] where PCR was used.
Moreover, with the exception of corona virus and PIV, the
proportions of viral species corresponded well to a study on
community acquired pneumonia in the same geographical area
[25]. The latter confirms an earlier finding that the temporal
occurrence of viral infections in immunocompromised patients
tends to mirror their occurrence in the community [15].
Approximately half of the viral findings were viremia with BKV
and CMV as dominating pathogens. A comparable screening in
young children with febrile neutropenia showed lower frequency
[5], but this discrepancy is probably explained by the fact that the
prevalence of latent viral infections increases with age. It has been
shown that allogeneic transplanted patients with a BK viral load of
more than 10
4 copies/mL had a significantly higher risk of having
hemorrhagic cystitis than patients with a viral load of less than 10
4
copies/mL [26]. In a recent pediatric study on a post-HSCT
population, the degree of BK viremia seemed to predict renal,
urologic, and overall outcome [27]. However, in our less
immunosuppressed cohort with mostly very low titers, we had
no reports on symptoms of disease associated to BKV.
Although we found an independent association between viral
findings and fever, one should interpret the results with caution
because of the discrepancy in grade of immunosuppression
between the febrile and afebrile patients. Furthermore, multivar-
iate analysis with this low number of patients carries the risk of
small sample bias. Even though the levels of virus in blood were
lower than those expected from symptomatic disease, the
independent association prompts the question whether the viral
load was sufficient to generate fever. Furthermore, not all viral
respiratory tract infections cause fever, and different virus types are
known to be variously pyrogenic [28]. In our study, not all patients
with fever were completely sampled for detection of viruses. We
thus risk underestimating the association between fever and viral
findings. Although bacterial culture is limited in sensitivity, it is of
interest to note that virus existed more often as the sole pathogen
identified here than as a cofactor with bacteria. The fact that PCR
is a highly sensitive method always raises the question of the
findings’ relevance. We did, however, determine an association
between respiratory viruses and URTS, indicating symptomatic
infection.
Until recently, viral infections were regarded as a concern in
hematological malignancies primarily in patients who had
undergone allogeneic HSCT. However, in the last years, the use
of monoclonal antibodies directed against B and/or T cells for
treatment of hematological malignancies such as NHL and CLL
has had potential to increase the incidence of viral infections in
these groups as well. These two diagnoses as well as receiving
monoclonal antibody therapy were associated to detection of virus
in our material. After multivariate analysis, only CLL showed to
be independently associated, but once again, with risk of small
sample bias.
Table 4. Upper respiratory tract symptoms and fever in the 144 neutropenic patients where NPA were obtained.
URTS No URTS Fever No fever OR (p)
Respiratory virus (n=35) (n=109) OR (p) (n=109) (n=35)
Rhinovirus 6 5
a 10
a 1
b
RSV 4 1 5 0
Adenovirus 2 4
a 6
a 0
Influenza A virus 0 1 1 0
Influenza B virus 2 0 2 0
Metapneumo virus 1 1 2 0
Total (%) 15 (43) 11 (10) 6.7 (,.0001) 25 (23) 1 (3) 10 (,.01)
NOTE. URTS, upper respiratory tract symptoms; OR, odds ratio; RSV, respiratory syncytial virus.
aOne case of co-infection of HRV and AdV.
bThis patient did not have URTS either.
doi:10.1371/journal.pone.0036543.t004
Figure 2. Documented microbiological pathogens in the 123
patients with febrile neutropenia.
doi:10.1371/journal.pone.0036543.g002
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risk factor for the development of lower respiratory tract infection
[29], and reconstitution of the lymphocyte population is known to
reduce the risk for viremia with CMV and AdV [30,31]. In our
study, all measured cell counts were lower in the virus-positive
patients but only the difference in CD4
+ cell count was statistically
significant. The function of lymphocytes can be altered by both the
treatment and the underlying disease [32] and it would therefore
be interesting to investigate an association between not only the
cell count but also the cell function to risk of viral infection in this
patient category.
In conclusion, both respiratory virus infections and low titers of
viruses in blood from patients with neutropenia were common.
Patients with CLL and patients with fever were independently
associated to these infections, and viral findings in NPA were
associated to URTS indicating active infection. Although this is a
small study in a heterogeneous group of hematological patients, it
is possible that a proportion of episodes of febrile neutropenia
could originate from virus infections. Larger prospective longitu-
dinal studies should be conducted to investigate the possible
causality between neutropenic fever and viral infections.
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